Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.

Hofer CB, Keiser O, Zwahlen M, Lustosa CS, Frota AC, de Oliveira RH, Abreu TF, Carvalho AW, Araujo LE, Egger M.

Pediatr Infect Dis J. 2016 Jan;35(1):71-7. doi: 10.1097/INF.0000000000000926.

PMID:
26741583
2.

The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.

Vreeman RC, Scanlon ML, McHenry MS, Nyandiko WM.

J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20258. doi: 10.7448/IAS.18.7.20258. eCollection 2015.

3.

Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.

Bhutia E, Hemal A, Yadav TP, Ramesh KL.

Afr Health Sci. 2014 Jun;14(2):408-13. doi: 10.4314/ahs.v14i2.17.

4.

Metabolic complications and treatment of perinatally HIV-infected children and adolescents.

Barlow-Mosha L, Eckard AR, McComsey GA, Musoke PM.

J Int AIDS Soc. 2013 Jun 18;16:18600. doi: 10.7448/IAS.16.1.18600. Review.

5.

Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial.

Kuhn L, Coovadia A, Strehlau R, Martens L, Hu CC, Meyers T, Sherman G, Hunt G, Persaud D, Morris L, Tsai WY, Abrams EJ.

Lancet Infect Dis. 2012 Jul;12(7):521-30. doi: 10.1016/S1473-3099(12)70051-8. Epub 2012 Mar 16.

6.

Nutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy.

Contri PV, Berchielli EM, Tremeschin MH, Negrini BV, Salomão RG, Monteiro JP.

Clinics (Sao Paulo). 2011;66(6):997-1002.

7.

Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy.

Brewinski M, Megazzini K, Hance LF, Cruz MC, Pavia-Ruz N, Della Negra M, Ferreira FG, Marques H, Hazra R; NISDI Pediatric Study Group 2010.

J Trop Pediatr. 2011 Oct;57(5):324-32. doi: 10.1093/tropej/fmq089. Epub 2010 Oct 1.

8.

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.

Coovadia A, Abrams EJ, Stehlau R, Meyers T, Martens L, Sherman G, Hunt G, Hu CC, Tsai WY, Morris L, Kuhn L.

JAMA. 2010 Sep 8;304(10):1082-90. doi: 10.1001/jama.2010.1278.

9.

LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.

Innes S, Levin L, Cotton M.

South Afr J HIV Med. 2009 Dec;10(4):76-80.

10.

Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children.

Buck WC, Kabue MM, Kazembe PN, Kline MW.

J Int AIDS Soc. 2010 Aug 6;13:31. doi: 10.1186/1758-2652-13-31.

11.

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.

Ananworanich J, Kosalaraksa P, Siangphoe U, Engchanil C, Pancharoen C, Lumbiganon P, Intasan J, Apateerapong W, Chuenyam T, Ubolyam S, Bunupuradah T, Lange J, Cooper DA, Phanuphak P; HIV-NAT 010 Study Team.

AIDS Res Ther. 2008 Oct 28;5:24. doi: 10.1186/1742-6405-5-24.

12.

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children.

Gonzalez-Tome MI, Amador JT, Peña MJ, Gomez ML, Conejo PR, Fontelos PM.

BMC Infect Dis. 2008 Oct 22;8:144. doi: 10.1186/1471-2334-8-144.

13.

Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.

Saitoh A, Haas RH, Naviaux RK, Salva NG, Wong JK, Spector SA.

Antimicrob Agents Chemother. 2008 Aug;52(8):2825-30. doi: 10.1128/AAC.00434-08. Epub 2008 Jun 9.

14.

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16.

15.

Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.

Saitoh A, Fenton T, Alvero C, Fletcher CV, Spector SA.

Antimicrob Agents Chemother. 2007 Dec;51(12):4236-42. Epub 2007 Sep 24.

Items per page

Supplemental Content

Write to the Help Desk